Literature DB >> 32468138

His bundle pacing: troubleshooting during follow-up.

Carsten W Israel1, Sona Tribunyan2.   

Abstract

Follow-up of pacemaker systems for His bundle pacing (HBP) requires electrocardiogram (ECG) knowledge and creative thinking. This relates to ventricular threshold measurement in which it can be difficult to distinguish between selective HBP and loss of capture with pseudofusion since, by definition, intrinsic QRS complexes and those selectively paced via the His bundle look identical. Threshold testing in HBP is best performed in unipolar pacing mode, recording of a 12-lead ECG and pacing in VVI mode significantly above the intrinsic rate. Peculiarities of HBP relate to oversensing by the His bundle lead of atrial activity or the His bundle potential itself, leading to ventricular asystole or incorrect measurements during sensing testing. Ventricular undersensing and the use of His bundle plus additional right ventricular leads may lead to complex ECGs. However, other daily pacemaker problems (such as tachycardia above the upper rate limit or premature beats) and specific phenomena (such as paradoxical cardiac memory) may also be demanding in ECG troubleshooting of HBP.

Entities:  

Keywords:  HBP; Oversensing; Pacemaker ECG; Pacemaker follow-up; Threshold measurement

Year:  2020        PMID: 32468138     DOI: 10.1007/s00399-020-00693-9

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  2 in total

1.  [How to: Basics of programming cardiac pacemakers].

Authors:  V Johnson; C Israel; J Schmitt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2022-05-23

2.  Ventricular Synchrony in Para-Hisian Cardiac Pacing as an Alternative for Physiological Cardiac Activation (Indirect Recruitment of the His Bundle?).

Authors:  Andres Di Leoni Ferrari; Guilherme Ferreira Gazzoni; Luis Manuel Ley Domingues; Jessica Caroline Feltrin Willes; Gustavo Chiari Cabral; Flavio Vinicius Costa Ferreira; Laura Orlandini Lodi; Gustavo Reis
Journal:  Arq Bras Cardiol       Date:  2022-02       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.